France fines Sanofi for bad-mouthing generics

05/14/2013 | Bloomberg

France's antitrust regulator fined drugmaker Sanofi $52.8 million for casting doubt with doctors and pharmacists about the safety and efficacy of generic versions of the blood-thinner Plavix. Regulators say Sanofi urged doctors to require prescriptions for the branded drug be dispensed as written and tried to persuade pharmacists to use Sanofi's generic version instead of others.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA